Literature DB >> 27161349

The Gut Microbiota and their Metabolites: Potential Implications for the Host Epigenome.

Mona Mischke1, Torsten Plösch2.   

Abstract

The gut microbiota represents a metabolically active biomass of up to 2 kg in adult humans. Microbiota-derived molecules significantly contribute to the host metabolism. Large amounts of bacterial metabolites are taken up by the host and are subsequently utilized by the human body. For instance, short chain fatty acids produced by the gut microbiota are a major energy source of humans.It is widely accepted that microbiota-derived metabolites are used as fuel for beta-oxidation (short chain fatty acids) and participate in many metabolic processes (vitamins, such as folic acid). Apart from these direct metabolic effects, it also becomes more and more evident that these metabolites can interact with the mammalian epigenetic machinery. By interacting with histones and DNA they may be able to manipulate the host's chromatin state and functionality and hence its physiology and health.In this chapter, we summarize the current knowledge on possible interactions of different bacterial metabolites with the mammalian epigenetic machinery, mostly based on in vitro data. We discuss the putative impact on chromatin marks, for example histone modifications and DNA methylation. Subsequently, we speculate about possible beneficial and adverse consequences for the epigenome, the physiology and health of the host, as well as plausible future applications of this knowledge for in vivo translation to support personal health.

Entities:  

Keywords:  (early life) nutrition; (early life) programming; Bacterial metabolites; Breast feeding; DNA methylation; Epigenetics; Histone modification

Mesh:

Substances:

Year:  2016        PMID: 27161349     DOI: 10.1007/978-3-319-31248-4_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Perspective: Advancing Understanding of Population Nutrient-Health Relations via Metabolomics and Precision Phenotypes.

Authors:  Stephanie Andraos; Melissa Wake; Richard Saffery; David Burgner; Martin Kussmann; Justin O'Sullivan
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

Review 2.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

3.  The genome, microbiome and evolutionary medicine.

Authors:  Robert C Brunham
Journal:  CMAJ       Date:  2018-02-12       Impact factor: 8.262

Review 4.  DNA methylation markers in obesity, metabolic syndrome, and weight loss.

Authors:  Mirian Samblas; Fermín I Milagro; Alfredo Martínez
Journal:  Epigenetics       Date:  2019-03-27       Impact factor: 4.528

Review 5.  Exploring the human microbiome from multiple perspectives: factors altering its composition and function.

Authors:  David Rojo; Celia Méndez-García; Beata Anna Raczkowska; Rafael Bargiela; Andrés Moya; Manuel Ferrer; Coral Barbas
Journal:  FEMS Microbiol Rev       Date:  2017-07-01       Impact factor: 16.408

Review 6.  Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development.

Authors:  Nelly Amenyogbe; Tobias R Kollmann; Rym Ben-Othman
Journal:  Front Pediatr       Date:  2017-05-24       Impact factor: 3.418

Review 7.  Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development.

Authors:  Jawara Allen; Cynthia L Sears
Journal:  Genome Med       Date:  2019-02-25       Impact factor: 11.117

Review 8.  MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities.

Authors:  Abraham Pedroza-Torres; Sandra L Romero-Córdoba; Montserrat Justo-Garrido; Iván Salido-Guadarrama; Rubén Rodríguez-Bautista; Sarita Montaño; Rodolfo Muñiz-Mendoza; Cristian Arriaga-Canon; Verónica Fragoso-Ontiveros; Rosa María Álvarez-Gómez; Greco Hernández; Luis A Herrera
Journal:  Front Oncol       Date:  2019-12-11       Impact factor: 6.244

Review 9.  DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease.

Authors:  Stella Tommasi; Ahmad Besaratinia
Journal:  Int J Environ Res Public Health       Date:  2019-08-05       Impact factor: 3.390

10.  Multi-omics profiling highlights lipid metabolism alterations in pigs fed low-dose antibiotics.

Authors:  Yue Hu; Yihe Zhang; Cong Liu; Rui Qin; Desheng Gong; Ru Wang; Du Zhang; Lianqiang Che; Daiwen Chen; Guizhong Xin; Fei Gao; Qi Hu
Journal:  BMC Genet       Date:  2020-09-21       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.